Skip to content

Medpace Voice

Tag: Regulatory Affairs

Clinical Development

[On-Demand Webinar] 3 Key Trends Transforming the Future of Rare Disease Clinical Development

  • February 4, 2026

Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs.

Clinical Development

[Webinar] The Complexities of Pediatric Rare Disease Trials: Regulatory and Operational Strategies for Success

  • January 25, 2022

In this on-demand webinar, Medpace experts share the operational and regulatory challenges associated with pediatric rare disease clinical trials.

Clinical Development

Partnership with Greenleaf Enhances Strategic Regulatory Affairs Capabilities

  • February 2, 2021

"This partnership strengthens our global Regulatory Affairs offering and allows us to expand our strategic capabilities to support our Sponsors’ programs.” - Jon Isaacsohn, MD,…

Clinical Development

Shortened Timelines for Regulatory Review by ANMAT Make Argentina an Excellent Choice for Clinical Research

  • July 27, 2017

Author: Wanda Dobrzanski M.D, Head of Clinical Operations Latin America, Medpace

On April 26th, The Ministry of Health in Argentina (ANMAT) issued a new regulation…